Accurate measurement of cytokine concentrations is a powerful and essential approach to the study of infl ammation. The enzyme-linked immunosorbent assay (ELISA) is a simple, low-cost analytical tool that provides both the specifi city and sensitivity required for the study of cytokines in vitro or in vivo. This communication describes a systematic approach to develop an indirect sandwich ELISA to detect and quantify cytokines, or other biomarkers, with accuracy and precision. Also detailed is the use of sequential ELISA assays to analyze multiple cytokines from samples with limited volumes. Finally, the concept of a multiplex ELISA is discussed with considerations given to cost and additional time required for development.
Cytokines are a cornerstone of any study that deals with infl ammation, whether it is an in vitro cell culture system or an in vivo animal model ( 1 ) . The cytokine profi le as a whole and the relative abundance of one cytokine, and the endogenous inhibitors, defi ne an infl ammatory process that is in motion ( 2 ) . Cytokines may be used to describe the nature of the insult, infection, or injury ( 3 ) , and may even be used to stage the disease process ( 4 ) . These studies revolve around the ability to detect, quantify, and discriminate a single cytokine from a multitude of biomolecules present in any given sample. One such method that is routinely used is the indirect sandwich enzyme-linked immunosorbent assay (ELISA).
The ELISA exploits the specifi city of antibodies (Abs) and uses them to capture and quantify an analyte of interest from a given volume of sample, and it does this with remarkable sensitivity (pg/mL or ~0.5 pM for a 15 kDa protein) ( 5 ) .
There are four basic steps involved in an indirect sandwich ELISA. (1) Capturing analyte from sample with capture antibody. (2) Detecting captured analyte with detection antibody (also specifi c for captured analyte) that is labeled with biotin. (3) Detection amplifi cation with streptavidin that has been conjugated with an enzyme, in most instances horseradish peroxidase (HRP). Each streptavidin molecule has multiple HRP molecules attached, and each detection antibody has multiple biotins attached. Alternatively, detection antibodies may be directly conjugated to HRP, thereby eliminating an incubation step, but at the cost of sensitivity. (4) Substrate addition and signal measurement via optical density (OD) with a microplate reader.
After each incubation step throughout the assay, unbound reactants are washed away. Also, due to the binding properties of the microplates used, the plates must be blocked with an inert protein, after coating with capture antibody, in order to prevent nonspecifi c binding (NSB) of the sample.
This simple method can be expanded to measure several analytes from a single aliquot of sample via the sequential ELISA ( 6 ) . In this instance, a single sample is removed from one ELISA plate and then incubated in a separate plate, since the fi rst plate should have only captured the cytokine detected by the antibody used for capturing the cytokine. An alternative to the sequential ELISA is the multiplex ELISA, which offers a more rapid and cost-effective alternative to sequential analysis. In this approach, multiple capture antibodies, with differing specifi cities, are printed into a single well in a microplate. Each printed "spot" of antibody is exclusive from the others (see Subheading 3.5 , Fig. 4 ). In this manner, it is possible to measure 17, or more, analytes from a single sample all at once. This chapter details the steps involved in developing an ELISA by way of checkerboard titrations of antibodies, as well as selecting the optimal blocking buffer and diluent via dose-response curve analysis. Also discussed is the use of a spike-recovery method to determine if cross-reactivity or loss of analyte exists between the separate ELISAs used in the sequential ELISA format. Finally, the multiplex ELISA is given consideration in terms of the principle, determination of cross-reactivity, and cost effi ciency compared to the standard ELISA.
1. Matched antibody pairs: Monoclonal for capture and either mono-or polyclonal biotinylated antibody for detection.
2. Recombinant proteins for cytokine standards. 5. Microarray printer: This is used to "print" capture antibody onto the bottom of the well of the microplate. This communication is based on our experience with a noncontact spotter, the Perkin Elmer Piezorray.
Materials and Equipment
6. Detection/imaging system: A system with high resolution is needed to resolve and detect the signal from the individual prints (150 nm diameter) in each well. We use a Li-Cor scanner which can also be used for other assays. This detects the infrared fl uorescence of each spotted cytokine which can then be quantifi ed using various software packages.
7. Automatic plate washer: An automatic plate washer is especially important for this multiplex assay. If manually washing, any contact of pipette tips to the spots in the well could result in a failed assay or even false-positive or -negative results.
1. Day #1 : Dilute the capture antibodies in a suitable volume of PBS to make four dilutions as shown in Fig. 1 (use the manufacturer's suggested dilution as a starting point).
2. Coat a 96-well high-binding microplate with 50 μ L/well of the appropriate dilution of capture Ab. Figure 1 Fig. 1 are only examples; however, a three-log range between high and low is usually suffi cient.)
6. After the plate has been blocked, wash and tap the plate.
Methods

Optimizing Antibody Concentrations (the Checkerboard)
7. Add 50 μ L/well of each standard to the plate, as depicted in 12. Wash plate: Add TMB substrate, 100 μ L/well, and incubate in the dark without shaking for 20-30 min. Periodic measurements at 590 nm should be performed to determine when to stop the reaction. The high standards, for each antibody titration, should have an OD 590 of at least 0.4-0.5 prior to stopping color development (see Note 5) . It is important to protect TMB substrate from light in order to limit nonenzyme-mediated substrate catalysis (see Note 6 for troubleshooting color development).
13. Stop the reaction with 1.5 N sulfuric acid, 100 μ L/well, and tap plate with hand to gently mix the solutions. The solution should turn yellow. 14. Scan plate with plate reader at 465 and 590 nm and use the delta OD (OD 465 −OD 590 ) as the OD data point.
15. To determine the optimal antibody concentrations, compare the signal-to-noise ratio for each antibody pairing by dividing the OD of each standard by the OD of its corresponding zero standard, i.e.: for Fig. 1 , divide the average OD of column 2, rows A and B, by the average OD of column 4, rows A and B.
The antibody dilution pairs that yield the highest overall ratios for each standard represent the optimal antibody concentrations (see Note 7). It is highly recommended to use a spreadsheet to simplify the calculation process.
Certain sample matrices, such as serum, plasma, or tissue homogenates, may produce high nonspecifi c background (NSB) levels of interference which may affect the range, precision, and accuracy of the assay. Often, the blocking and dilution buffers used can exacerbate or diminish the level of NSB that a sample or the antibodies used impart on the assay. These effects are important to account for when selecting the blocking/dilution buffer, and the extent to which the sample should be diluted. The actual matrix dilutions to test are also dependent upon the sensitivity of the assay and the prevalence of the analyte in the sample. A dose-response test example is provided in Fig. 2 . The optimal buffer choice is that which yields the least amount of difference in OD between the 0, 10, and 50% sample 4. Prepare the detection Ab in each dilution buffer (without sample matrix!) using the optimal dilution determined in Subheading 3.1 . Add to plate as depicted in Fig. 2 .
5. Add SA-HRP, TMB, and sulfuric acid in the appropriate sequence and read as normal.
6. Again, the optimal buffer system contains the smallest differences between the dilution buffer + standards and the dilution buffer + standards + sample matrix.
All the basic ELISA steps covered in the previous section apply here for analyte quantifi cation. Expounded upon herein are the construction, modeling, and evaluation of a standard curve.
ELISAs have a dose-response curve shape that is sigmoidal; therefore, linear curve fi tting models are inappropriate. The fourparameter logistic (4PL) fi t is generally acknowledged to be the reference model of choice for ELISAs ( 7 ) . As the name suggests, the 4PL model calculates on the basis of four parameters: 
There are numerous commercial software packages that perform the calculations. Also, analysis software is usually available from the manufacturer of the plate reader. Sample ODs should fall within the steeper area of the curve for the most accurate quantitation. If the sample OD is on or near the top plateau of the curve, the samples should be assayed again, but at a higher dilution in order to place them in the steep portion. If the sample OD is at the lower end of the curve, determine if the sample can be run more concentrated based off the results of the dose-response data generated in Subheading 3.2 .
Ultimately, the users should defi ne the range of acceptable accuracy for their curve by preparing standards of known concentrations that differ from those used in the curve, and treating these samples as unknowns. The calculated value should be within 80-120% of the expected value. This process is frequently referred to as "spike and recovery."
This method uses the same protocol as the standard ELISA; however, the same samples can be run, sequentially, on multiple cytokine ELISA plates. This is particularly useful when the amount of sample available is limited.
A word of caution: Prior to assaying samples, it should be determined if there is cross-reactivity between the different ELISAs. To determine this, perform a spike and recovery, in which a known amount of each protein to be tested is spiked into a normal control sample and tested in the sequential ELISA format. An acceptable recovery range is 80-120%. Furthermore, samples should only be sequentially assayed in the same order as for which the spike-recovery performance was determined.
1. Coat the various cytokine ELISA plates as normal.
2. Wash only one plate, block, and add standard and samples as normal.
3. During the second hour of sample/standard incubation for the fi rst plate, wash and block the second plate.
4. Before washing the fi rst plate, transfer the samples from the fi rst plate back to the source plate, as shown in Fig. 3 , and then wash the plate as normal. Add detection Ab to the fi rst plate
The Sequential ELISA
and the standard and samples to the second plate, as shown in Table 1 .
5. Wash the fi rst plate and add the SA-HRP. Transfer the samples from the second plate back to the source plate and wash the second plate. Then, add detection Ab to the second plate. We have measured up to three separate cytokines using the sequential ELISA (see Note 9).
Two possible ways to measure multiple analytes from one sample include the cytometric bead array (CBA) and the multiplex ELISA. The CBA is a fl ow cytometry-based method in which specialized beads are coated with specifi c antibodies to the analytes of interest. Commercial kits are available that can provide measurement of up to 30 proteins from 25 to 50 μ L of sample. If one desires, beads may be purchased without specifi c antibodies attached. This allows the user to customize the assay according to need. The general 3.5. The Multiplex ELISA Fig. 3 . A conceptual Illustration of the sequential ELISA. After the samples are subjected to one ELISA for cytokine 1, they are transferred back to a source plate for storage until they are used in the ELISA for cytokine 2, so on and so forth. The steps after the sample incubation are as normal for the particular ELISA adapted from ref. 6 . method is as such: Beads are conjugated in various intensities with a dye which fl uoresces strongly within a specifi c channel fi lter (i.e., FL3). This creates distinct populations for data acquisition. Next, each specifi c population of these beads is coated with a specifi c capture antibody for the target of interest. Samples are then incubated with the "capture beads," followed by incubation with a detection antibody conjugated to a fl uorophore that emits light into a different fi lter channel than that of the capture bead (i.e., FL2). The FL2 fl uorescence is in direct proportion to the amount of analyte present while the FL3 fl uorescence indicates the specifi c analyte present ( 8 ) . This method uses less sample volume than a single ELISA; however, the cost may be prohibitive because the user is required to buy kits. The multiplex ELISA is another way to measure multiple analytes from one sample and is further discussed below. Due to the nature of the multiplex ELISA, specialized equipment is required. This necessitates a sizable initial investment; however, because of the high throughput and reduced labor, the cost per assay is substantially lower. There are signifi cant differences in the printing apparatuses between manufacturers of the specialized equipment; as such, this section covers general considerations in developing a multiplex ELISA.
Due to the similarities between the standard single ELISA and the multiplex, similar optimization techniques can be used to develop the assay. The checkerboard described in Subheading 3.1 can be used to determine the optimal concentrations of antibodies and standards for the multiplex assay. In this instance, however, the standard and detection Ab must be added to each well as a cocktail because in each well there is essentially multiple, simultaneous ELISAs occurring (see Fig. 4 for illustration and Table 2 for list of analytes in the multiplex).
1. The ELISA plates must fi rst be printed with the capture antibody specifi c for the cytokines of interest. Again, the printing process is specifi c to the printer used, and the manufacturer's recommendations should be followed. 50,000 pg/mL/cytokine followed by twofold serial dilutions is suffi cient (i.e.: dilutions of 1×, 2×, 4×, n ×., 16,384×, or, 50,000-3.05 pg/mL).
5. Incubate standards, samples, and the detection Ab cocktail as with the standard ELISA procedure. For the sake of simplicity, dilute all detection Abs into the cocktail at the same concentration.
6. After the detection cocktail incubation is complete, wash the plate and add the streptavidin dye conjugate diluted in dilution buffer, 50 μ L/well, and incubate for 30 min in the dark (see Note 11).
7. Wash the plate and dry thoroughly by spinning upside down in a centrifuge. 9. Scan and analyze as suggested by the specifi c system used.
As with the sequential ELISA, cross-reactivity poses a potential problem in a multiplex assay and the issue should be addressed prior to analyzing a sample. An experimental approach to determine the presence of cross-reactivity is listed in Table 3 .
An obvious advantage of the multiplex versus the standard ELISA is the greater amount of data generated from a single sample and within the same window of time. Less obvious is the money saved 
using the multiplex approach. The comparison is not straightforward and varies from lab to lab. Without regards to specialized equipment, the multiplex is more expensive than a standard ELISA on a per plate basis. However, when compared using a data per sample basis, the multiplex becomes more cost-effi cient than the standard ELISA. For example, our lab has found that it is more cost-effective to use the multiplex when measuring seven cytokines or more. This takes into account the cost of antibodies, technician time, and overhead costs (see Table 4 for an example comparison). To be most effi cient, samples that require 7+ cytokine measurements are stored until there are enough samples to fi ll an entire plate. 2. It is acceptable, but cumbersome, to manually wash the plates with a multichannel pipette. It is not advisable to use a squirt bottle for washing because wash fl uid from one well can spill into another, skewing results. Additionally, it is possible to leave the plates soaking in wash buffer for up to an hour; however, it is recommended that this is determined empirically for your ELISAs. 3 . Any length of time may be used for each incubation so long as the incubation times used in the checkerboarding step of development are used going forward. It is likely that shorter incubation times will require an increased concentration of reactants. For instance, our lab has a standard IL-6 ELISA assay that takes 6+ hours to complete. We also have a rapid IL-6 ELISA that can be performed in less than 90 min and is useful when a rapid value is necessary ( 9 ) .
Notes
4. The optimal dilution for SA-HRP typically remains the same across different cytokine ELISAs. This needs to be determined only once.
5. There is a linear relationship between the OD 590 and the ΔOD ( 10 ) . An OD 590 of 0.4-0.5 translates to a ΔOD of ~ 1.2-1.6 (see Note 7).
6. There are several reasons why a plate may turn uniformly blue or not change color at all. Uniform color development across the plate may be due to the following: (1) User coated with biotinylated detection Ab instead of unlabeled capture antibody. ( 2) The biotinylated antibody has degraded causing NSB. (3) Too much capture and/or detection antibody was used. This is especially true in the initial stages of development 7. The optimal dilution of antibody may not have the highest signal-to-noise ratio for the top standard when compared to other dilutions. The signal:noise of the low and mid standard should guide your selection. This is because the OD of the top standard is likely representative of saturation of the system (either the capture or the detection Ab is not in excess to standard). What is important, however, is that the top standard has an OD around 1.5 or higher. ODs above 1.5-1.7 are unreliable for quantitative measurements in many plate readers ( 11 ) , but they are a good starting point for the top standard. If the OD of the top standard does not reach this area, the range of the standard curve is decreased. If raising the concentration of standard does not increase the OD, it is likely that either the capture or detection antibodies are limiting.
8. The upper asymptote is a result of the standard being in excess to the capture or detection antibodies. It is important that this asymptote does not exceed the linear range of the plate reader being used. Decreasing capture or detection antibody concentrations decrease the maximum OD observed; however, there may be a trade-off in sensitivity of the ELISA. If sensitivity cannot be sacrifi ced, it is advisable to investigate the fi veparameter logistic (5PL) fi t model as an alternative to the 4PL. The 5PL can better handle curves with asymmetries such as those that may come from not achieving an upper or lower asymptote. Regardless of which curve model is selected, the OD of the standards must be within the linear range of the plate reader.
9. Samples can be stored overnight at 4°C to continue the sequential ELISAs the next day, since each additional plate adds 2 hours to the time devoted to the assay.
10. Printed plates may be stored for up to 6 months at 4°C. It is recommended to determine the stability of the printed plates under the conditions in your lab.
11. As with many fl uorophores, exposure to ambient light may result in photobleaching. Care should be taken to limit the exposure of the IR dye to light.
